Diphenylmethyl,Cefoselis

Product Description

CAS No.:122841-12-7
Other Names:Cefoselis sulfate
MF:C19H24N8O10S3
Type:Auxiliaries and Other Medicinal Chemicals
Grade Standard:Cosmetic Grade, Feed Grade, Food Grade, Medicine Grade, Tech Grade
Usage:Animal Pharmaceuticals
Purity:99%
Appearance:White Powder
CAS:122841-12-7
Certificate:COA
Grade:Phamaceutical Grade
Assay:99% Min
Sample:Availiable
COA:Avaialble

Cefoselis is a widely used beta-lactam antibiotic

Cefoselis has a broad antibacterial spectrum against Gram-positive bacteria. This substance is the 4th generation cephalosporin. Cefoselis has some side effects, such as convulsions and convulsions in the elderly and patients with renal failure. The dialysate and blood samples were detected by HPLC. Cefoselis appeared in the striatal dialysate sample in a dose-dependent manner, but disappeared rapidly in the extracellular fluid. In rats with renal failure, the elimination half-life of cefoselis is prolonged. This may be the cause of convulsions caused by cefotaxi. In addition, the use of cefoselis in the hippocampus can cause an increase in extracellular glutamate and a slight increase in GABA, indicating that cefoselis can cause convulsions by blocking GABA receptors